vTv Therapeutics (VTVT) Notes Payables (2014 - 2025)

vTv Therapeutics has disclosed Notes Payables across 10 years of filings, most recently posting $328000.0 for Q3 2025.

• In Q3 2025, Notes Payables changed N/A year-over-year to $328000.0; the TTM figure through Sep 2025 stood at $328000.0 (changed N/A YoY), while the FY2023 annual figure was $191000.0, down 14.73% from the prior year.
• Notes Payables came in at $328000.0 for Q3 2025 at vTv Therapeutics, up from $191000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $636000.0 in Q3 2021 to a low of $191000.0 in Q4 2023.
• Average Notes Payables over 4 years is $380714.3, with a median of $328000.0 recorded in 2025.
• The largest YoY upside for Notes Payables was 204.76% in 2021 against a maximum downside of 73.15% in 2021.
• Over 4 years, Notes Payables stood at $256000.0 in 2021, then declined by 12.5% to $224000.0 in 2022, then retreated by 14.73% to $191000.0 in 2023, then soared by 71.73% to $328000.0 in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $328000.0 in Q3 2025, $191000.0 in Q4 2023, and $473000.0 in Q3 2023.